Kazia Therapeutics (KZIA) Asset Utilization Ratio (2011 - 2017)
Kazia Therapeutics (KZIA) posted Asset Utilization Ratio of 0.53 for Q2 2017, up 51.02% on a QoQ basis from 0.35 in Q4 2016, and up 74.85% year-over-year from 0.31 in Q2 2016.
Kazia Therapeutics (KZIA) Asset Utilization Ratio (2011 - 2017) Analysis & Trends
Kazia Therapeutics' Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 0.53 for Q2 2017.
- Quarterly Asset Utilization Ratio rose 74.85% year-over-year to 0.53 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was 0.53 (up 74.85% YoY) and the FY2025 annual result came in at 0.0, down 96.78% from the prior year.
- Asset Utilization Ratio was 0.53 for Q2 2017 at Kazia Therapeutics, up from 0.35 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.53 in Q2 2017 and bottomed at 0.09 in Q4 2013.
- A 4-year average of 0.29 and a median of 0.31 in 2016 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2013 — Asset Utilization Ratio slumped 94.79% — and 2016, when it surged 110.86%.
- Kazia Therapeutics' Asset Utilization Ratio stood at 0.09 in 2013, then jumped by 92.97% to 0.17 in 2015, then soared by 110.86% to 0.35 in 2016, then jumped by 51.02% to 0.53 in 2017.
- Business Quant data shows KZIA's Asset Utilization Ratio at 0.53 in Q2 2017, 0.35 in Q4 2016, and 0.31 in Q2 2016.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.69 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.47 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.37 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 0.53 |
| Dec 31, 2016 | 0.35 |
| Jun 30, 2016 | 0.31 |
| Dec 31, 2015 | 0.17 |
| Dec 31, 2013 | 0.09 |
| Dec 31, 2012 | 1.66 |
| Dec 31, 2011 | 1.98 |